Search Results
Jun 02, 2026, 05:37 ET Hyundai Motor lance le film de campagne mondiale « Le futur commence maintenant » pour la Coupe du monde de la FIFA 2026™.
Coupe du monde est toujours un moment passionnant, car elle met en valeur la nouvelle génération de joueurs sur la plus grande scène du monde. Je suis parfaitement en phase avec la campagne « Le futur commence maintenant » de Hyundai Motor, qui met en lumière les futurs talents tout en délivrant un message
More news about: Hyundai Motor Company
Jun 02, 2026, 04:00 ET AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults
single attack and the consistency of effect across multiple attacks in adults with a history of migraine, with or without aura.1 The study met its primary endpoint, demonstrating that AQUIPTA was superior to placebo in achieving pain freedom at two hours after treatment of the first migraine
More news about: AbbVie
Jun 02, 2026, 03:00 ET Yozma viert eenjarig bestaan met historische samenwerking met de Belgische Rode Duivels
krijgen om kennis te maken met de Yozma IN 10, een elektrische offroadmotor die de sensatie van offroadrijden combineert met een stillere, schonere en toegankelijkere rijervaring.Met de lancering van zijn campagne
More news about: Yozmasports
Jun 02, 2026, 02:00 ET Un nouveau rapport de Thunes révèle un déficit d'interopérabilité des paiements transfrontaliers, l'innovation locale s'arrêtant aux frontières
révèle une disparité frappante entre les attentes des consommateurs et la réalité de réseaux transfrontaliers, lents et fragmentés. Le rapport met également en évidence un angle mort critique dans le secteur financier : bien que les systèmes de paiement locaux soient plus rapides et plus avancés
More news about: Thunes
Jun 02, 2026, 00:12 ET Computex 2026 : SSSTC élargit sa gamme de SSD à refroidissement par immersion pour répondre aux défis thermiques des centres de données d'IA
à l'égard du refroidissement par air traditionnel tout en améliorant l'efficacité énergétique (PUE) et la fiabilité globale du système.SSSTC met également en avant une gamme de SSD industriels et d'entreprise optimisés pour l'IA et les applications à la périphérie. Les SSD industriels prennent
More news about: SSSTC
Jun 01, 2026, 21:30 ET MSI presenteert vloeistofgekoelde AI-infrastructuur, NVIDIA MGX, NVIDIA DGX Station en DC-MHS-platformen op COMPUTEX 2026
gestandaardiseerde implementatie binnen bestaande datacenteromgevingen. Geconfigureerd met 16 x 2U2N-multinodesystemen, maakt het platform schaalbare cloud- en ondernemingsinfrastructuurintegratie mogelijk met standaard EIA-rekken, met zowel AMD EPYCTM 9005- als Intel® Xeon® 6-platformopties voor flexibele implementatie.NVIDIA
More news about: MSI
Jun 01, 2026, 11:00 ET IDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combination in First Line HLA*A2:01 Negative Metastatic Uveal Melanoma in a Late-Breaking Oral Presentation at ASCO
Findings from OptimUM-02Primary endpoint (Phase 2 portion): progression free survival by BICRThe trial met the primary endpoint, with patients treated with the darovasertib combination demonstrating a statistically significant improvement in median PFS of
More news about: IDEAYA Biosciences, Inc.
Jun 01, 2026, 09:00 ET Bitwise Debuts Inaugural Tokenized Fund, the Bitwise Crypto Carry Fund, in Partnership with Superstate
popularity, acceptance or use, which may impact their price.There is no guarantee or assurance that an investor's investment objectives will be met through an investment into any Bitwise investment product, and an investor may lose all or a portion of the investment. Investors into any Bitwise investment
More news about: Bitwise Asset Management
Jun 01, 2026, 09:00 ET Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance
trial, funded by a grant from the U.S. Department of Defense and conducted in collaboration with Cleveland Clinic, in which all primary endpoints were met."Anixa's ovarian cancer vaccine is based on immunizing against AMHR2, a protein expressed in normal ovaries prior to menopause and also aberrantly
More news about: Anixa Biosciences, Inc.
Jun 01, 2026, 08:39 ET RAAPID Achieves HITRUST r2 Certification, Demonstrating Commitment to Cybersecurity and Information Protection
RAAPID has met requirements defined by a leading cybersecurity assurance leader, confirming that strong controls are in place to protect sensitive data and manage risk
More news about: RAAPID INC
Jun 01, 2026, 07:43 ET New Memoir Chronicles a Legally Blind Student's Journey Through College, Friendship and Faith
embarrassments, so you must always treasure those who remained closest to you in those most trying and humbling moments," Johnson said. "The people I met during those years changed my life in ways I never expected, and this memoir is as much a tribute to them as it is a story about me.""The Bum
More news about: Archway Publishing
Jun 01, 2026, 07:25 ET GOFO op DELIVER Europe 2026 als genomineerde voor de Rising Star Award
van de volgende groeifase heeft GOFO Peter van Keulen benoemd tot Head of Sales voor Nederland. Met zijn brede ervaring in de logistieke sector zal Peter zich richten op het opbouwen van partnerships met middelgrote en grote e-commercebedrijven die willen profiteren van GOFO's landelijke netwerkdekking
More news about: GOFO
Jun 01, 2026, 05:28 ET GOSS DEADLINE ALERT: Hagens Berman Alerts Gossamer Bio (GOSS) Investors to Today's Lead Plaintiff Deadline in Securities Class Action
the price of Gossamer shares down by 80%.After the Class Period, on April 9, 2026, the company revealed that since February 24, 2026 it has not met the minimum share bid price ($1) required for continued listing on the Nasdaq Global Select Market."We're focused on whether Gossamer may have
More news about: Hagens Berman Sobol Shapiro LLP
May 31, 2026, 09:00 ET HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session
liver metastases, or brain metastases. At the pre-specified interim analysis, as assessed by the Independent Data Monitoring Committee (IDMC), the study met its key secondary endpoint of overall survival (OS), demonstrating both clinically a meaningful and statistically significant benefit.As of the
More news about: Akeso, Inc.
May 31, 2026, 08:29 ET RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
yet reached, as reported in new Journal of Clinical Oncology publication RYBREVANT FASPRO™, an EGFR- and MET-targeting dual inhibitor, is the first and only subcutaneous therapy being evaluated in this setting Johnson & Johnson submitted
More news about: Johnson & Johnson
May 31, 2026, 08:27 ET Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm
surgery, significantly improved key short- and long-term clinical outcomes for patients with high-risk localized or locally advanced disease. The trial met both primary endpoints. Patients treated with apalutamide plus hormone therapy were nine times more likely to have little to no cancer remaining at the
More news about: Johnson & Johnson
May 31, 2026, 08:01 ET Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
placebo in patients with early-stage (IB-IIIA) rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC). The study met its primary endpoint, demonstrating a highly statistically significant and clinically meaningful improvement in investigator-assessed event-free survival
More news about: Eli Lilly and Company
May 31, 2026, 05:31 ET Zendure en Sunergy bundelen hun krachten om slim energiebeheer voor woningen in Nederland te versnellen.
AC+, ontworpen om naadloos te integreren met bestaande PV-systemen. Met een AC-gekoppeld plug-and-play-ontwerp, tweerichtingsopbrengst tot 2400 W en een uitbreidbare capaciteit van 2,4 kWh tot 16,8 kWh biedt het een flexibele en schaalbare opslagoplossing.Met behulp van AI-gedreven energiebeheer (ZENKI
More news about: Zendure DE GmbH
May 31, 2026, 00:05 ET Huawei voor het vierde jaar op rij benoemd tot leider in het Gartner® Magic Quadrant™ 2026 voor Enterprise Wired- en Wireless LAN-infrastructuur
het netwerk: Huaweis Xinghe AI Campus Solution is uitgerust met krachtige AI-gedreven geautomatiseerde O&M-mogelijkheden. Door gebruik te maken van iFlows analyse van alle processen, kan de oplossing binnen enkele minuten gebieden met een lage QoE (Quality of Experience) lokaliseren, het volledige
More news about: Huawei
May 30, 2026, 22:33 ET Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contenders
approximately 4,100 submissions from 125 countries and regions this year, setting a new historical record. According to the Festival, around 3,000 films met the eligibility requirements for competition, while 82% of the submitted entries are world or international premieres. The Festival also expanded its
More news about: SIFF
May 30, 2026, 20:09 ET Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026
include acquired resistance mutations and CNS metastasis. DZD6008 was designed to address these clinical issues. The data presented confirmed that DZD6008 met our design criteria and has the potential to provide an oral safe treatment option for these patients. We are very excited by the clinical data. We look
More news about: Dizal Pharmaceutical
May 30, 2026, 09:57 ET GOSS 2-DAY DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS
the price of Gossamer shares down by 80%.After the Class Period, on April 9, 2026, the company revealed that since February 24, 2026 it has not met the minimum share bid price ($1) required for continued listing on the Nasdaq Global Select Market."We're focused on whether Gossamer may have
More news about: Hagens Berman Sobol Shapiro LLP
May 30, 2026, 09:00 ET Real Estate Expert Justus Smith of Keystone Explains Where Real Estate Commission Dollars Go for HelloNation
coordination across all parties involved. Smith emphasizes that agents manage inspections, appraisals, and financing milestones, ensuring that deadlines are met and communication stays consistent. The HelloNation article notes that this coordination prevents costly delays and helps deals reach closing smoothly.
More news about: HelloNation
May 30, 2026, 08:00 ET GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting
blood test to NHS screening could reduce the combined number of cancers diagnosed at Stage III or IV over three years. The primary endpoint was not met. However, a pre-specified secondary endpoint did show a greater than 20% reduction in Stage IV cancers, with the effect strengthening by the third year
More news about: GRAIL, Inc.
May 30, 2026, 06:29 ET EngineAI ra mắt cơ sở sản xuất thông minh tại Thâm Quyến, lô robot hình người T800 đầu tiên xuất xưởng, bắt đầu giao hàng quy mô lớn
Với diện tích khoảng 12.000 mét vuông, cơ sở tại Thâm Quyến được trang bị quy trình sản xuất khép kín tích hợp, bao phủ toàn bộ các công đoạn từ kiểm tra nguyên vật liệu đầu vào, kiểm
More news about: EngineAI